Surgery – Miscellaneous – Methods
Patent
1993-08-26
1995-08-01
Yasko, John D.
Surgery
Miscellaneous
Methods
604 19, 604 49, 604 51, 514210, 4242361, 4242391, 424581, A61B 1900
Patent
active
054372917
ABSTRACT:
Direct injection of sphincteric botulinum toxin is disclosed as an effective, safe and simple method of treatment for disorders of gastrointestinal muscle or smooth muscles elsewhere in the body, with results that appear to be sustained for several months. Muscle disorders which are suitable for such treatment include achalasia, isolated disorders of the lower esophageal sphincter, gastroparesis, hypertrophic pyloric stenosis, sphincter of Oddi dysfunction, short-segment Hirschsprung's, anal fissure, hemorrhoids, proctalgia fugax, irritable bowel syndrome, disorders of the upper esophageal sphincter, vasospastic disorders, and disorders of uterine and bladder spasm. Devices suitable for delivering this therapy are also disclosed.
REFERENCES:
patent: 4203983 (1980-05-01), Yelnosky et al.
patent: 4713391 (1987-12-01), Chiang et al.
patent: 4725593 (1988-02-01), Davis
patent: 4904673 (1990-02-01), Eberlein et al.
patent: 4927629 (1990-05-01), Bing
patent: 4932936 (1990-06-01), Dykstra et al.
patent: 4957941 (1990-09-01), Davis et al.
patent: 5053005 (1991-10-01), Borodic
patent: 5071844 (1991-12-01), Alker et al.
patent: 5145859 (1992-09-01), Fleischmann
patent: 5171217 (1992-12-01), March et al.
patent: 5298019 (1994-03-01), Borodic
Carpenter "Potentiation of Nerve-Induced Bladder Responses by Tetraethylammonium in Relation to Junctional and Extrajunctional Muscarinic Receptors," Br. J. Pharmac., 64:331-339 (1978).
Dykstra, et al., "Effects of Botulinum a Toxin on Detrusor-Sphincter Dyssynergia in Spinal Cord Injury Patients," J. Urology, 139:919-922 (May 1988).
Dykstra, et al., "Treatment of Detrusor-Sphincter Dyssynergia With Botulinum A toxin: A Double-Blind Study," Arch Phys Med Rehabil, 71:24-26 (Jan. 1990).
Carpenter, "Motor Responses of the Urinary Bladder and Skeletal Muscle in Botulinum Intoxicated Rats," J. Physiol. 188:1-11 (1967).
Pasricha, et al., "Treatment of Achalasia With Intrasphincteric Injection of Botulinum Toxin-Results of a Pilot Study," AGA/AASLD Abstracts, May 1993.
Pasricha, et al., "Treatment of Sphincter of ODDI(SO) Dysfunction With Botulinum Toxin (BoTx) Injection-Case Report," ASGE Abstract, May 1993.
Pasricha, et al., "Injection of Botulinum Toxin (BoTx) Into The Distal Esophageal Sphincter (DES) in Piglets-A Unique Investigative Technique with Potential Therapeutic Uses," Amer. J. Gastroenterology, 87:1255, abstract (1992).
Pasricha, et al., "Botulinum Toxin for Achaiasia," The Lancet, 341:244-245 (1993).
Bigalke, et al., "Blackade by Tetanus and Botulinum A Toxin of Postganglionic Cholinergic Nerve Endings in the Myenteric Plexus," Naunyn-Schniedebergs's Arch. Pharmacol., 312:255-253 (1980).
Jankovic, et al., "Therapeutic Uses of Botulinum Toxin," The New Engl. J. Med., 324:1186-1194 (1991).
Lees, "Botulinum Toxin," BMJ:305(6863):1169-1170 (1992).
Dickson, et al., "Botulism: Studies on the Manner in Which the toxin of Clostridium Botulinum Acts Upon the Body," J. Exper. Med., 37:711-731 (1923).
MacKenzie, et al, "The Effects of Purified Botulinum Neurotoxin Type A on Cholinergic, Adrenergic, and Non-Adrenergic, Atropine-Resistant Neuromuscular Transmission," Neuroscience, 7(4):997-1006 (1982).
International Search Report for PCT/US 94/09759 Dated Dec. 21, 1994.
Kalloo Anthony N.
Pasricha Pankai J.
Smith Chalin
Yasko John D.
LandOfFree
Method for treating gastrointestinal muscle disorders and other does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating gastrointestinal muscle disorders and other , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating gastrointestinal muscle disorders and other will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-728960